BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16200274)

  • 1. [Cardiovascular events: a class effect by COX-2 inhibitors].
    Araujo LF; Soeiro Ade M; Fernandes Jde L; Serrano Júnior CV
    Arq Bras Cardiol; 2005 Sep; 85(3):222-9. PubMed ID: 16200274
    [No Abstract]   [Full Text] [Related]  

  • 2. Lessons to learn from the COX-2 saga. Yes, FDA reforms are needed. And marketing distorts how medications are used. But one moral to the story is that all drugs have risks.
    Harv Health Lett; 2005 Mar; 30(5):1-3. PubMed ID: 16526110
    [No Abstract]   [Full Text] [Related]  

  • 3. COX-2 inhibitors and the heart: putting risk in perspective.
    Bobadilla RV; Barnett EM; Randels CL
    Adv Nurse Pract; 2005 Nov; 13(11):48-50. PubMed ID: 16295003
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclooxygenase-2 inhibitors and cardiovascular risk.
    Smith ER
    Can J Cardiol; 2005 Mar; 21(3):307-8. PubMed ID: 15776124
    [No Abstract]   [Full Text] [Related]  

  • 5. [Innovation of anti-inflammatory drugs--inhibition of cyclooxygenases].
    Guo ZR
    Yao Xue Xue Bao; 2005 Nov; 40(11):967-9. PubMed ID: 16499077
    [No Abstract]   [Full Text] [Related]  

  • 6. Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk.
    Motsko SP; Rascati KL; Busti AJ; Wilson JP; Barner JC; Lawson KA; Worchel J
    Drug Saf; 2006; 29(7):621-32. PubMed ID: 16808554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COX-2 inhibitors--a lesson in unexpected problems.
    Drazen JM
    N Engl J Med; 2005 Mar; 352(11):1131-2. PubMed ID: 15713947
    [No Abstract]   [Full Text] [Related]  

  • 8. COX-2 inhibitors and cardiovascular toxicity: a class effect?
    Laible B
    S D J Med; 2005 Mar; 58(3):93-4. PubMed ID: 15794479
    [No Abstract]   [Full Text] [Related]  

  • 9. COX-2 inhibitors and cardiovascular risk. Inferences based on biology and clinical studies.
    Marwali MR; Mehta JL
    Thromb Haemost; 2006 Oct; 96(4):401-6. PubMed ID: 17003914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COX-2 selective inhibitors and heart health.
    Simon LS; White WB
    Postgrad Med; 2005 Jan; 117(1 Suppl):7-20. PubMed ID: 19667717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COX-2 inhibitors and the heart: are all coxibs the same?
    Sooriakumaran P
    Postgrad Med J; 2006 Apr; 82(966):242-5. PubMed ID: 16597810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of thrombotic cardiovascular events in patients taking celecoxib compared with those taking rofecoxib: interim results from the New Zealand Intensive Medicines Monitoring Programme.
    Harrison-Woolrych M; Herbison P; McLean R; Ashton J; Slattery J
    Drug Saf; 2005; 28(5):435-42. PubMed ID: 15853444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The COX-2 inhibitors--an update.
    Furberg CD
    Am Heart J; 2006 Aug; 152(2):197-9. PubMed ID: 16875896
    [No Abstract]   [Full Text] [Related]  

  • 14. Concerns about COX-2 painkillers. They're easier on the stomach, potentially harder on your heart.
    Heart Advis; 2002 Jan; 5(1):2. PubMed ID: 16145759
    [No Abstract]   [Full Text] [Related]  

  • 15. [Are there any differences in the cardiovascular tolerance between classical NSAIDs and coxibs?].
    Valat JP; Deray G; Héloire F
    Presse Med; 2006 Sep; 35(9 Spec No 1):1S25-34. PubMed ID: 17078592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [COX-2 inhibitors--one step forward and two steps back].
    Evensen S; Spigset O; Slørdal L
    Tidsskr Nor Laegeforen; 2005 Apr; 125(7):875-8. PubMed ID: 15815733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coxibs: can this class of drugs survive?
    Tabrizchi R
    Vasc Health Risk Manag; 2005; 1(1):5-8. PubMed ID: 17319092
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.
    McGettigan P; Henry D
    JAMA; 2006 Oct; 296(13):1633-44. PubMed ID: 16968831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COX-2 inhibitors in patients with sensitivity to nonselective NSAIDs.
    Cimbollek S; Quiralte J; Avila R
    N Engl J Med; 2009 Nov; 361(22):2197-8. PubMed ID: 19940308
    [No Abstract]   [Full Text] [Related]  

  • 20. Celecoxib.
    Cheung R; Lowry S
    J R Soc Med; 2006 Jul; 99(7):336. PubMed ID: 16816261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.